NXAT
NXAT
1.20$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
NXAT (NXAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 78,081 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | 0.2 | – | – | -14 | 0.1 | 10 | 17 | 11 | 78,081 | 78,120 | |
| – | – | – | – | – | – | – | – | – | 0.2 | 6.3 | 6.1 | -12 | 0.1 | 9.5 | 13 | 10 | 71,203 | 71,236 | |
| – | – | – | – | – | – | – | – | – | 0.0 | 0.8 | 0.8 | -1.5 | -0.1 | 0.8 | 4.2 | 0.9 | 6,878 | 6,884 | |
| – | – | – | – | – | – | – | – | 2.2 | 3.6 | – | – | – | 1.5 | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.4 | 0.4 | 2.2 | 3.6 | 0.7 | 0.7 | 8.9 | 2.5 | 13 | 61 | 14 | 201,605 | 201,694 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.3 | -0.4 | -0.4 | -2.2 | -3.6 | -0.8 | -0.6 | -10 | -2.5 | -12 | -56 | -13 | -194,728 | -194,810 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.2 | – | 1.5 | 3,904 | – | |
| 0.0 | 0.0 | 0.0 | – | -0.2 | 0.5 | 0.6 | 0.8 | -2.2 | -3.6 | -0.1 | 0.1 | -9.9 | -3.5 | -0.6 | -60 | -15 | -207,675 | -207,750 | |
| – | – | – | – | – | 0.1 | 0.2 | 0.2 | – | – | 0.1 | 0.1 | 0.0 | – | 0.0 | 0.2 | 0.0 | 435 | 435 | |
| 0.0 | 0.0 | 0.0 | – | -0.2 | 0.4 | 0.4 | 0.5 | -2.2 | -3.6 | -0.2 | -0.1 | -10 | -3.5 | -0.6 | -59 | -15 | -205,743 | -205,817 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.3 | -0.4 | -0.4 | -2.1 | -3.6 | 0.5 | 0.5 | -11 | -2.5 | -0.7 | -8.2 | -13 | -203,771 | -203,793 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.